文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹毛发、甲与色素性疾病

免疫介导性炎症性皮肤病对工作的影响:系统综述与荟萃分析

Work impact of immune-mediated inflammatory skin diseases: A systematic review and meta-analysis.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2026-08-10

该系统综述与荟萃分析纳入100项研究、累计306,619名参与者,评估斑秃、特应性皮炎、化脓性汗腺炎、银屑病和白癜风对工作生产力的影响。结果显示,皮肤IMIDs与工作功能受损持续相关,WPAI总体工作损害均值为28.96(95%CI 25.61; 32.31),年均病假16.74天(95%CI 7.39; 26.1)。

要点

  • 皮肤IMIDs患者WPAI总体工作损害均值28.96,提示工作功能显著受损。
  • 患者年均病假16.74天,职业负担明确且可量化。
  • 职业损害受心理社会因素影响,需多学科策略预防职业劣势。

核心结论

  • 皮肤IMIDs在全球范围内显著降低工作功能与生产力,构成被低估的负担。
  • 职业损害反映更广泛的心理与社会后果,临床评估常未捕捉。
  • 亟需全球框架标准化工作相关结局评估,并推动多学科协作。

研究设计与样本

  • 系统综述与荟萃分析,检索8个电子数据库至2024年6月。
  • 纳入报告成人(≥18岁)斑秃、特应性皮炎、化脓性汗腺炎、银屑病或白癜风工作相关结局的定量研究。
  • 荟萃分析要求报告WPAI、WLQ或病假时长;两名评审独立筛选与提取数据。
  • 采用频次学派与贝叶斯方法合并数据,以增强异质性设计与样本量下的稳健性。

主要发现

  • 共纳入100项研究,累计样本306,619名参与者,遍布全球。
  • 皮肤IMIDs与工作功能受损持续相关。
  • WPAI总体工作损害均值为28.96(95%CI 25.61; 32.31)。
  • 参与者年均病假16.74天(95%CI 7.39; 26.1)。
  • 职业损害受心理社会因素影响,提示更广泛的社会与经济后果。

关键数值与推荐

  • WPAI总体工作损害均值28.96(95%CI 25.61; 32.31)。
  • 年均病假16.74天(95%CI 7.39; 26.1)。
  • 纳入病种:斑秃、特应性皮炎、化脓性汗腺炎、银屑病、白癜风。
  • 纳入年龄:成人≥18岁。

临床怎么用

  • 临床评估应关注皮肤IMIDs患者的工作功能与生产力损害。
  • 可将WPAI等工作相关结局工具纳入常规评估,识别职业劣势风险。
  • 需多学科协作(患者、医护人员、职业健康专家、方法学家)整合工作结局至疾病负担指标与卫生政策。

局限性

  • 即使使用WPAI等验证工具,工作相关结局测量仍缺乏国际共识。
  • 职业损害受心理社会因素影响,临床与卫生系统评估常未捕捉。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with immune-mediated inflammatory diseases (IMIDs) of the skin face challenges beyond visible signs. Despite their significant psychosocial burden, the global impact of skin IMIDs on work productivity has not been systematically reviewed. OBJECTIVE: To evaluate the global burden of skin IMIDs on work productivity. METHODS: We conducted a systematic review and meta-analysis. Eight electronic databases (PubMed, Web of Science Core Collection, Embase, SciELO, KCI Korean Journal Database, Global Index Medicus, Informit and Google Scholar) were searched from inception to June 2024. We included quantitative studies reporting work-related outcomes in adults (≥18 years) with alopecia areata, atopic dermatitis, hidradenitis suppurativa, psoriasis or vitiligo. For the meta-analysis, studies had to report Work Productivity and Activity Impairment (WPAI), Work Limitations Questionnaire (WLQ) or sick leave duration. Two reviewers independently screened and extracted data. Risk of bias was assessed using validated tools. Data were pooled using frequentist and Bayesian approaches to ensure estimations robustness across heterogeneous designs and sample sizes. RESULTS: Across 100 studies with a cumulative sample of 306,619 participants worldwide, skin IMIDs were consistently associated with impaired work functioning. Notably, the mean WPAI overall work impairment was 28.96 (95% CI 25.61; 32.31), and participants averaged 16.74 days of sick leave per year (95% CI 7.39; 26.1). Findings suggest that occupational impairment was influenced by psychosocial factors, thereby highlighting broader societal and economic consequences. CONCLUSION: Skin IMIDs substantially reduce work functioning and productivity worldwide, representing an underrecognized burden on individuals, employers and health systems. Better multidisciplinary strategies are needed to prevent occupational disadvantage and mitigate the economic and social impact of these chronic conditions. Our findings demonstrate that immune‐mediated inflammatory skin diseases meaningfully impair work productivity worldwide, revealing an overlooked dimension of disease burden with direct consequences for health equity, labour markets and economic stability. These occupational impairments reflect broader psychological and societal consequences that are rarely captured in clinical or health systems assessments. By highlighting the lack of international consensus on measuring work‐related outcomes—even when validated tools such as the Work Productivity and Activity Impairment questionnaire are used—this study underscores the urgent need for global frameworks to standardize evaluation of work‐related outcomes across chronic conditions. Multidisciplinary collaboration among patients, healthcare professionals, occupational health specialists and methodologists will be essential to better integrate work‐related outcomes into disease burden metrics, health policy and global development agendas.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Kpenou FC, Han JH, Fadel M, et al. Work impact of immune-mediated inflammatory skin diseases: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2026. PMID: 42573445. doi:10.1111/jdv.70653

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。